India has one of the first places in the world in the number of COVID cases
–
–
Vaccines are powerless against a strain with a double mutation. It was first discovered in the Indian state of Maharashtra.
In India, scientists have identified 63 cases of breakthrough infection – a disease in which a vaccinated person falls ill with the same disease that a COVID drug should prevent. RIA Novosti.
Most of those infected who have already received one or two injections of the coronavirus vaccine were infected with the B.1.617 SARS-CoV-2 strain, which includes three strains. This is stated in a study by specialists from the All India Institute of Medical Sciences in Delhi and the Institute of Genomics and Integrative Biology.
“Our analysis included 63 cases of breakthrough infection … 36 patients received two doses of vaccine, while 27 received one dose of vaccine. Ten patients received Covishield and 53 received Covaxin. The median age of patients was 37 years (21-92 years). ), including 41 men and 22 women. None of the patients had comorbidities that could serve as a predisposing factor for breakthrough infections, “the doctors said.
They added that after the study, a strain from the B.1.617 line was found in most of the patients.
“B.1.617.2 turned out to be the predominant line with 23 samples, of which 12 were fully vaccinated and 11 partially vaccinated. Four samples and one sample were assigned to lines B.1.617.1 and B.1.1.7, respectively”, – emphasized by the doctors.
Strain B.1.617 was first discovered in the Indian state of Maharashtra.
Earlier it was reported that in India began to pray to the goddess COVID… In the temple of the city of Coimbatore, two statues of the Crown Devi appeared. The priests leave food for them and bathe them in water and milk.
Recall in India prisoners refuse to be released… The prisoners fear for their lives due to the situation with the coronavirus, therefore they refuse the right to parole.
News from Correspondent.net in Telegram. Subscribe to our channel https://t.me/korrespondentnet
– .
